Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-09-12
1992-08-18
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549264, A61K 31365, C07D31500
Patent
active
051400421
ABSTRACT:
Fermentation of S. erythraea produces the novel avermectin, 28-hydroxy ivermectin aglycone.
REFERENCES:
patent: 4530921 (1985-07-01), Mrozik
patent: 4581345 (1986-04-01), Wyvratt, Jr.
patent: 4743592 (1988-05-01), Jutsum
patent: 4812582 (1989-03-01), Nelson
Arison Byron H.
Doherty Patrick J.
Schulman Marvin D.
DiPrima Joseph F.
Ivy C. Warren
Merck & Co. , Inc.
Owens Ameha A.
Rose David L.
LandOfFree
28-hydroxy ivermectin aglycone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 28-hydroxy ivermectin aglycone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 28-hydroxy ivermectin aglycone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1249319